Vanessa Merker

Vanessa Merker

Harvard University - Cambridge / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 1421420
person_outline Vanessa Merker's MOST POPULAR ARTICLES
1-) Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients Otology & Neurotology 33 (6), 1046-1052, 2012
2-) Clinical features of schwannomatosis: a retrospective analysis of 87 patients The oncologist 17 (10), 1317-1322, 2012
3-) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis PloS one 7 (4), e35711, 2012
4-) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation Genetics in Medicine 24 (9), 1967-1977, 2022
5-) Efficacy and biomarker study of bevacizumab for hearing loss resulting from neurofibromatosis type 2–associated vestibular schwannomas Journal of Clinical Oncology 34 (14), 1669-1675, 2016